Perseid Therapeutics' Acquisition

Perseid Therapeutics was acquired by Astellas Pharma on May 12, 2011.

Perseid Therapeutics develops protein-therapeutic drugs to improve human health. In May 2011, Perseid Therapeutics was acquired by Astellas Pharma. The valuation of Perseid Therapeutics was $76 milli…

Articles about Perseid Therapeutics' Acquisition: